Replacement of Dietary Saturated Fatty Acids by Trans Fatty Acids Lowers Serum HDL Cholesterol and Impairs Endothelial Function in Healthy Men and Women

We tested whether trans fatty acids and saturated fatty acids had different effects on flow-mediated vasodilation (FMD), a risk marker of coronary heart disease (CHD). Consumption of trans fatty acids is related to increased risk of CHD, probably through effects on lipoproteins. Trans fatty acids differ from most saturated fatty acids because they decrease serum high-density lipoprotein (HDL) cholesterol, and this may increase the risk of CHD. We fed 29 volunteers 2 controlled diets in a 2×4-week randomized crossover design. The “Trans-diet” contained 9.2 energy percent of trans fatty acids; these were replaced by saturated fatty acids in the “Sat-diet.” Mean serum HDL cholesterol after the Trans-diet was 0.39 mmol/L (14.8 mg/dL), or 21% lower than after the Sat-diet (95% CI 0.28 to 0.50 mmol/L). Serum low density lipoprotein and triglyceride concentrations were stable. FMD+SD was 4.4±2.3% after the Trans-diet and 6.2±3.0% after the Sat-diet (difference −1.8%, 95% CI −3.2 to −0.4). Replacement of dietary saturated fatty acids by trans fatty acids impaired FMD of the brachial artery, which suggests increased risk of CHD. Further studies are needed to test whether the decrease in serum HDL cholesterol caused the impairment of FMD.

[1]  E. Rocha [Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease]. , 2000, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[2]  K. L. Berry,et al.  Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation. , 2000, Clinical science.

[3]  I. Meredith,et al.  Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. , 2000, Journal of the American College of Cardiology.

[4]  G. Flaker,et al.  Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events? , 2000, American heart journal.

[5]  K. Kostner,et al.  Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. , 2000, Journal of the American College of Cardiology.

[6]  C. Hayward,et al.  Effect of fat and carbohydrate consumption on endothelial function , 1999, The Lancet.

[7]  C. Meisner,et al.  Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. , 1999, American heart journal.

[8]  J. Kooner,et al.  Hyperhomocysteinemia : An Effect Reversible With Vitamin C Therapy Demonstration of Rapid Onset Vascular Endothelial Dysfunction After , 1999 .

[9]  J. Simons,et al.  Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults. , 1999, Atherosclerosis.

[10]  D. Allison,et al.  Estimated intakes of trans fatty and other fatty acids in the US population. , 1999, Journal of the American Dietetic Association.

[11]  H Kesteloot,et al.  Intake of fatty acids in Western Europe with emphasis on trans fatty acids: The TRANSFAIR study , 1999, European Journal of Clinical Nutrition.

[12]  E. Decker,et al.  High-fat meals and endothelial function. , 2009, Nutrition reviews.

[13]  B. Psaty,et al.  Assessment of trans-fatty acid intake with a food frequency questionnaire and validation with adipose tissue levels of trans-fatty acids. , 1998, American journal of epidemiology.

[14]  C. Meisner,et al.  Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease , 1998, Heart.

[15]  M. Malloy,et al.  Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy. , 1998, The Journal of pediatrics.

[16]  A. Kafatos,et al.  Trans fatty acids in foods in Europe : the TRANSFAIR study , 1998 .

[17]  G. De Backer,et al.  Epidemiological aspects of high density lipoprotein cholesterol. , 1998, Atherosclerosis.

[18]  J. Simons,et al.  Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia. , 1998, Atherosclerosis.

[19]  P. Fletcher,et al.  Reproducibility of brachial ultrasonography and flow-mediated dilatation (FMD) for assessing endothelial function. , 1997, Australian and New Zealand journal of medicine.

[20]  G. Plotnick,et al.  Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. , 1997, JAMA.

[21]  K. Woo,et al.  Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. , 1997, Circulation.

[22]  E. Whitney,et al.  Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl. , 1997, The American journal of cardiology.

[23]  D. Celermajer,et al.  Endothelial dysfunction: does it matter? Is it reversible? , 1997, Journal of the American College of Cardiology.

[24]  O. Pedersen,et al.  Intake of a Diet High in Trans Monounsaturated Fatty Acids or Saturated Fatty Acids: Effects on postprandial insulinemia and glycemia in obese patients with NIDDM , 1997, Diabetes Care.

[25]  M. Jauhiainen,et al.  Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. , 1997, The American journal of clinical nutrition.

[26]  M. Creager,et al.  Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. , 1997, Circulation.

[27]  R. Pathmanathan,et al.  Trans (elaidic) fatty acids adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans. , 1997, The Journal of nutrition.

[28]  D. Glogar,et al.  Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. , 1997, Atherosclerosis.

[29]  G. Plotnick,et al.  Effect of a single high-fat meal on endothelial function in healthy subjects. , 1997, The American journal of cardiology.

[30]  A. Donker,et al.  Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[31]  M W Ramsey,et al.  Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes , 1996, BMJ.

[32]  J. Deanfield,et al.  Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. , 1996, The New England journal of medicine.

[33]  G. Plotnick,et al.  Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. , 1996, The American journal of cardiology.

[34]  Y. Ouchi,et al.  Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. , 1995, Circulation.

[35]  M. Mancini,et al.  Lipid-lowering treatment: effects on endothelial dysfunction. , 1995, Current opinion in lipidology.

[36]  G. Mancini,et al.  Effects of vitamin E on endothelial function in men after myocardial infarction. , 1995, The American journal of cardiology.

[37]  P. Durrington,et al.  HDL, its enzymes and its potential to influence lipid peroxidation. , 1995, Atherosclerosis.

[38]  D. Spiegelhalter,et al.  Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. , 1995, British heart journal.

[39]  P. Durrington,et al.  HDL, its enzymes and its potential to influence lipid peroxidation , 1995 .

[40]  H. Blackburn,et al.  Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. , 1995, Preventive medicine.

[41]  R. Mensink,et al.  Dietary trans fatty acids and lipoprotein cholesterol. , 1995, The American journal of clinical nutrition.

[42]  W. Weintraub,et al.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.

[43]  R. Mensink,et al.  Effects of fats and fatty acids on blood lipids in humans: an overview. , 1994, The American journal of clinical nutrition.

[44]  S. Hohnloser,et al.  Elevated High-Density Lipoprotein Levels Ameliorate Abnormal Vasoconstriction in Early Atherosclerosis , 2005 .

[45]  J. Wittes,et al.  Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. , 1994, The American journal of clinical nutrition.

[46]  D. Betteridge,et al.  Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. , 1994, The Journal of clinical investigation.

[47]  D. Celermajer,et al.  Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults , 1993, Circulation.

[48]  J. Manson,et al.  Intake of trans fatty acids and risk of coronary heart disease among women , 1993, The Lancet.

[49]  E. Mohler,et al.  Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. , 1991, The American journal of cardiology.

[50]  R. Mensink,et al.  Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. , 1990, The New England journal of medicine.

[51]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.